InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.19) by 15.79 percent. This is a 27.27 percent increase over losses of $(0.22) per share from the same period last year. The company reported quarterly sales of $3.398 million which beat the analyst consensus estimate of $2.698 million by 25.93 percent. This is a 122.24 percent increase over sales of $1.529 million the same period last year.